全文获取类型
收费全文 | 25687篇 |
免费 | 1887篇 |
国内免费 | 384篇 |
专业分类
耳鼻咽喉 | 278篇 |
儿科学 | 492篇 |
妇产科学 | 428篇 |
基础医学 | 2763篇 |
口腔科学 | 601篇 |
临床医学 | 2910篇 |
内科学 | 3739篇 |
皮肤病学 | 174篇 |
神经病学 | 2877篇 |
特种医学 | 1718篇 |
外国民族医学 | 1篇 |
外科学 | 4235篇 |
综合类 | 2321篇 |
一般理论 | 1篇 |
预防医学 | 1203篇 |
眼科学 | 327篇 |
药学 | 2136篇 |
23篇 | |
中国医学 | 556篇 |
肿瘤学 | 1175篇 |
出版年
2024年 | 51篇 |
2023年 | 468篇 |
2022年 | 875篇 |
2021年 | 1299篇 |
2020年 | 1225篇 |
2019年 | 1099篇 |
2018年 | 1115篇 |
2017年 | 955篇 |
2016年 | 855篇 |
2015年 | 880篇 |
2014年 | 1650篇 |
2013年 | 1803篇 |
2012年 | 1247篇 |
2011年 | 1461篇 |
2010年 | 1077篇 |
2009年 | 1137篇 |
2008年 | 1058篇 |
2007年 | 1086篇 |
2006年 | 945篇 |
2005年 | 765篇 |
2004年 | 643篇 |
2003年 | 526篇 |
2002年 | 430篇 |
2001年 | 390篇 |
2000年 | 299篇 |
1999年 | 331篇 |
1998年 | 301篇 |
1997年 | 298篇 |
1996年 | 273篇 |
1995年 | 251篇 |
1994年 | 228篇 |
1993年 | 207篇 |
1992年 | 190篇 |
1991年 | 176篇 |
1990年 | 197篇 |
1989年 | 169篇 |
1988年 | 175篇 |
1987年 | 147篇 |
1986年 | 170篇 |
1985年 | 210篇 |
1984年 | 223篇 |
1983年 | 183篇 |
1982年 | 197篇 |
1981年 | 146篇 |
1980年 | 108篇 |
1979年 | 95篇 |
1978年 | 75篇 |
1977年 | 65篇 |
1976年 | 59篇 |
1973年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
《Seminars in Arthroplasty》2022,32(4):681-687
BackgroundThe objective of this study was to compare complication rates between patients undergoing reverse shoulder arthroplasty (RSA) after a prior open reduction and internal fixation (ORIF) for proximal humerus fracture (PHF) to those undergoing RSA as a primary treatment for PHFs, glenohumeral osteoarthritis, or rotator cuff tear arthropathy (CTA).MethodsPatients who underwent RSA between 2015 and 2020 were identified in the Mariner database. Patients were separated into 3 mutually exclusive groups: (1) RSA for osteoarthritis, rotator cuff tear, or CTA (Control-RSA); (2) RSA as a primary treatment for PHF (PHF-RSA); and (3) RSA for patients with prior ORIF of PHFs (ORIF-RSA). Ninety-day medical and 2-year postoperative surgical complications were identified. In addition, patients in the PHF-RSA group were subdivided into those undergoing RSA for PHF within 3 months of the fracture (acute) vs. those treated greater than 3 months from diagnosis (delayed). Multivariate regression was performed to control for differences in comorbidities and demographics.ResultsA total of 30,824 patients underwent primary RSA for arthritis or CTA, 5389 patients underwent RSA as a primary treatment for a PHF, and 361 patients underwent RSA after ORIF of a PHF. ORIF before RSA was associated with an increased risk of overall revision (odds ratio [OR] 2.45, P = .002), infection (OR 2.40, P < .001), instability (OR 2.43, P < .001), fracture (OR 3.24, P = .001), minor medical complications (OR 1.59, P = .008), and readmission (OR 2.55, P = .001) compared with the Control-RSA cohort. RSA as a primary treatment for PHF was associated with an increased risk of 2-year revision (OR 1.60, P < .001), infection (OR 1.51, P < .001), instability (OR 2.84, P < .001), and fracture (OR 2.54, P < .001) in addition to major medical complications (OR 2.02, P < .001), minor medical complications (OR 1.92, P < .001), 90-day emergency department visits (OR 1.26, P < .001) and 90-day readmission (OR 2.03, P < .001) compared with the Control-RSA cohort. The ORIF-RSA group had an increased risk of periprosthetic infection (OR 1.94, P = .002) when compared with the PHF-RSA cohort. There were no differences in medical or surgical complications in the RSA-PHF cohort between patients treated in an acute or delayed fashion.ConclusionRSA following ORIF of a PHF is associated with increased complications compared with patients undergoing RSA for nonfracture indications. Prior ORIF of a PHF is also an independent risk factor for postoperative infection after RSA compared with patients who undergo RSA as a primary operation for fracture. The timing of RSA as a primary operation for PHF does not appear to impact the rates of postoperative medical and surgical complications. 相似文献
4.
5.
《The British journal of oral & maxillofacial surgery》2022,60(4):499-506
The aim of this study was to carry out a retrospective multicentre study comparing the morphological outcome of 8 techniques used for the management of sagittal synostosis versus a large cohort of control patients. Computed tomographic (CT) images were obtained from children CT-scanned for non-craniosynostosis related events (n = 241) and SS patients at preoperative and postoperative follow-up stages (n = 101). No significant difference in morphological outcomes was observed between the techniques considered in this study. However, the majority of techniques showed a tendency for relapse. Further, the more invasive procedures at older ages seem to lead to larger intracranial volume compared to less invasive techniques at younger ages. This study can be a first step towards future multicentre studies, comparing surgical results and offering a possibility for objective benchmarking of outcomes between methods and centres. 相似文献
6.
7.
Canada continues to experience an escalating opioid overdose crisis that has claimed more than 8000 lives in the country since 2016. The presence of the synthetic opioid fentanyl and its analogues is a central contributor to the increases in preventable opioid-related deaths. However, a number of converging social-structural factors (e.g., the continued criminalisation of drug use, political changes) and political barriers are also complicating and contributing to the current crisis. We briefly outline four harm reduction interventions (i.e., injectable opioid agonist treatment, naloxone distribution programs, overdose prevention sites, and drug checking services) as emerging and rapidly expanding responses to this crisis in Canada. These examples of innovation and expansion are encouraging but also occurring at the same time that the opioid overdose crisis shows few signs of abating. To truly address the crisis, Canada needs political environments at all government levels that are responsive and foster harm reduction innovation and drug policy experimentation. 相似文献
8.
目的:探讨3D-CRT 低剂量区 V5体积的大小对非小细胞肺癌患者肺功能的影响。方法:收集我院肿瘤科2014年4月~2015年10月收治的46例首次行三维适形放射治疗且顺利完成治疗的非小细胞肺癌患者,对每例患者分别在治疗前以及治疗后的1、3个月进行肺功能检测,分析3D-CRT 低剂量区 V5体积的大小与肺功能变化之间的关系。结果:放疗后1个月的 FEV1%、FVC%值明显高于放疗前且差异均具有显著性。放疗后1个月、3个月的 DLCO%值明显低于放疗前,且放疗前的与放疗后3个月的差异具有显著性;V5≦45%、45%55%三组放疗前后的 FEV1%值和 FVC%值比较差异均不具有显著性。V5≦45%、45%55%三组放疗前后的 DLCO%值均呈逐渐下降趋势,且 V5>55%组的放疗前后 DLCO%值比较差异具有显著性。而 V5≦45%组和45%55%时,DLCO%值降低的趋势更加显著。 相似文献
9.
10.